The 4S Study and its Pharmacoeconomic Implications

This publication has 17 references indexed in Scilit:

• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Screening experience and baseline characteristics in the West of Scotland coronary prevention study
  The American Journal of Cardiology, 1995
• Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
  The American Journal of Cardiology, 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)
  The American Journal of Cardiology, 1993
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Should there be a moratorium on the use of cholesterol lowering drugs?
  BMJ, 1992
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The Netherlands
  The American Journal of Cardiology, 1990
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987